Julia Aniscenko

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Induction of neutralising antibodies against conserved rhinovirus capsid protein VP4 is dependent on presentation of VP4 peptide immunogens in a virus-like conformation.

Induction of neutralising antibodies against conserved rhinovirus capsid protein VP4 is dependent on presentation of VP4 peptide immunogens in a virus-like conformation.

Journal: PLoS pathogens

Published: December 18, 2025

Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection.

Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection.

Journal: The Journal of allergy and clinical immunology

Published: November 02, 2021

Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations In Vivo: A Clinical Trial.

Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations In Vivo: A Clinical Trial.

Journal: American journal of respiratory and critical care medicine

Published: September 01, 2021

Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.

Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.

Journal: Thorax

Published: April 09, 2021

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.

Journal: The Journal of allergy and clinical immunology

Published: July 13, 2020

Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models.

Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models.

Journal: Chest

Published: February 08, 2020

Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.

Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.

Journal: The Journal of allergy and clinical immunology

Published: November 22, 2019

Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192].

Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192].

Journal: Antiviral research

Published: March 20, 2019

Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.

Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.

Journal: The Journal of clinical investigation

Published: March 15, 2019

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations.

Journal: International journal of chronic obstructive pulmonary disease

Published: October 25, 2018

Corrigendum: Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.

Corrigendum: Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.

Journal: Nature medicine

Published: November 09, 2017

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

Journal: Nature communications

Published: September 11, 2017

Showing 1-12 of 24

Last Updated: 09/26/2026